GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Athersys Inc (FRA:4LSA) » Definitions » Cyclically Adjusted Book per Share

Athersys (FRA:4LSA) Cyclically Adjusted Book per Share : €0.00 (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Athersys Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Athersys's adjusted book value per share for the three months ended in Sep. 2023 was €-1.562. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Athersys's average Cyclically Adjusted Book Growth Rate was -11.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -10.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Athersys was -10.30% per year. The lowest was -25.70% per year. And the median was -20.20% per year.

As of today (2024-05-29), Athersys's current stock price is €0.045. Athersys's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was €0.00. Athersys's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Athersys was 9.38. The lowest was 0.01. And the median was 3.30.


Athersys Cyclically Adjusted Book per Share Historical Data

The historical data trend for Athersys's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athersys Cyclically Adjusted Book per Share Chart

Athersys Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.05 7.83 6.20 5.49 5.01

Athersys Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.72 5.01 5.29 5.05 -

Competitive Comparison of Athersys's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Athersys's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athersys's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Athersys's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Athersys's Cyclically Adjusted PB Ratio falls into.



Athersys Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Athersys's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book= Book Value per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-1.562/129.8595*129.8595
=-1.562

Current CPI (Sep. 2023) = 129.8595.

Athersys Quarterly Data

Book Value per Share CPI Adj_Book
201312 5.118 98.326 6.759
201403 6.958 99.695 9.063
201406 7.355 100.560 9.498
201409 6.712 100.428 8.679
201412 5.452 99.070 7.146
201503 5.363 99.621 6.991
201506 5.731 100.684 7.392
201509 4.146 100.392 5.363
201512 5.407 99.792 7.036
201603 6.790 100.470 8.776
201606 5.200 101.688 6.641
201609 4.175 101.861 5.323
201612 3.059 101.863 3.900
201703 6.135 102.862 7.745
201706 5.120 103.349 6.433
201709 4.679 104.136 5.835
201712 4.045 104.011 5.050
201803 6.985 105.290 8.615
201806 8.686 106.317 10.609
201809 7.690 106.507 9.376
201812 6.566 105.998 8.044
201903 5.489 107.251 6.646
201906 4.847 108.070 5.824
201909 3.948 108.329 4.733
201912 3.277 108.420 3.925
202003 2.518 108.902 3.003
202006 7.232 108.767 8.634
202009 4.744 109.815 5.610
202012 3.191 109.897 3.771
202103 3.733 111.754 4.338
202106 2.847 114.631 3.225
202109 2.651 115.734 2.975
202112 1.491 117.630 1.646
202203 0.028 121.301 0.030
202206 -1.009 125.017 -1.048
202209 -1.297 125.227 -1.345
202212 -1.252 125.222 -1.298
202303 -1.570 127.348 -1.601
202306 -1.582 128.729 -1.596
202309 -1.562 129.860 -1.562

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Athersys  (FRA:4LSA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Athersys was 9.38. The lowest was 0.01. And the median was 3.30.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Athersys Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Athersys's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Athersys (FRA:4LSA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Athersys Inc (FRA:4LSA) » Definitions » Cyclically Adjusted Book per Share
Traded in Other Exchanges
Address
3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634
Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Athersys (FRA:4LSA) Headlines

No Headlines